Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May;20(2):208-217.
doi: 10.5853/jos.2018.00150. Epub 2018 May 31.

Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications

Affiliations
Review

Intracranial Large Artery Disease of Non-Atherosclerotic Origin: Recent Progress and Clinical Implications

Oh Young Bang et al. J Stroke. 2018 May.

Abstract

Intracranial large artery disease (ILAD) is the major cause of stroke worldwide. With the application of recently introduced diagnostic techniques, the prevalence of non-atherosclerotic ILAD is expected to increase. Herein, we reviewed recent reports and summarized progress in the diagnosis and clinical impact of differentiation between ILAD of atherosclerotic and non-atherosclerotic origin. Our review of the literature suggests that more careful consideration of non-atherosclerotic causes and the application of appropriate diagnostic techniques in patients with ILAD may not only provide better results in the treatment of patients, but it may also lead to more successful clinical trials for the treatment of intracranial atherosclerosis.

Keywords: Atherosclerosis; Intracranial; Ischemic stroke; Magnetic resonance imaging; Stenosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Prevalence of intracranial large artery disease of non-atherosclerotic origin demonstrated by high-resolution magnetic resonance imaging (HR-MRI) in (A) non-stroke subjects,[62] (B) young-age stroke patients,[63] and (C) acute stroke patients[64]. TIA, transient ischemic attack; PD, proton-density; Gd, gadolinium-enhancement. *Middle cerebral artery disease; † Excluding cases with typical luminal features of intracranial atherosclerosis (multiple tandem stenosis or carotid stenosis), moyamoya disease, or intracranial dissection; ‡ Both anterior and posterior circulation disease.
Figure 2.
Figure 2.
Trends of moyamoya disease (MMD) and intracranial atherosclerosis in Korea. (A) Increase in the number of publications on MMD and (B) increasing annual incidence of patients diagnosed with MMD in East Asian countries (nationwide data), with a decrease in the proportion of patients with anterior circulation intracranial atherosclerosis (A-ICAS) (nationwide hospital-based data)[65]-.

References

    1. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352:1305–1316. - PubMed
    1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003. - PMC - PubMed
    1. Leung TW, Wang L, Soo YO, Ip VH, Chan AY, Au LW, et al. Evolution of intracranial atherosclerotic disease under modern medical therapy. Ann Neurol. 2015;77:478–486. - PubMed
    1. Wong KS, Gao S, Chan YL, Hansberg T, Lam WW, Droste DW, et al. Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol. 2002;52:74–81. - PubMed
    1. Ryoo S, Lee MJ, Cha J, Jeon P, Bang OY. Differential vascular pathophysiologic types of intracranial atherosclerotic stroke: a high-resolution wall magnetic resonance imaging study. Stroke. 2015;46:2815–2821. - PubMed